BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:35 PM
 | 
Jul 21, 2010
 |  BC Extra  |  Clinical News

NovaBay reports NVC-422 data

NovaBay Pharmaceuticals Inc. (NYSE-A:NBY) said thrice-daily low-, mid- and high-dose topical NVC-422 for seven days produced clinical response...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >